Home Newsfeeds NexImmune Q2 EPS $(0.69) Down From $(0.54) YoY

NexImmune Q2 EPS $(0.69) Down From $(0.54) YoY

NexImmune (NASDAQ:NEXI) reported quarterly losses of $(0.69) per share. This is a 27.78 percent decrease over losses of $(0.54) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

NexImmune (NASDAQ:NEXI) reported quarterly losses of $(0.69) per share. This is a 27.78 percent decrease over losses of $(0.54) per share from the same period last year.

East Meets Green: TotalEnergies and Sinopec Team Up for Low-Carbon Future

By Lekha Gupta

May 7, 8:26 AM

TotalEnergies SE and SINOPEC have signed a strategic cooperation agreement to develop sustainable energy solutions, including sustainable aviation fuel.

EIPX

News

Affimed Announced Publication In The Journal mAbs On Leveraging FcRn-pH-HPLC As A Method To Select Bispecific Antibodies With Optimal Developability

By Charles Gross

August 22, 5:14 AM

Affimed N.V. (NASDAQ:AFMD) ("Affimed", or the "Company"), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the

AFMD